Aveanna Healthcare (NASDAQ:AVAH) CFO Sells $145,865.28 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 17,448 shares of the company’s stock in a transaction dated Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total transaction of $145,865.28. Following the completion of the sale, the chief financial officer directly owned 472,609 shares in the company, valued at approximately $3,951,011.24. The trade was a 3.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Matthew Buckhalter also recently made the following trade(s):

• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02.

Aveanna Healthcare Price Performance

Shares of AVAH stock opened at $8.08 on Monday. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm’s 50 day moving average is $8.92 and its 200-day moving average is $7.52. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds have recently bought and sold shares of the company. Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare during the first quarter worth $25,000. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare during the 2nd quarter worth $43,000. Diversified Trust Co bought a new position in Aveanna Healthcare during the second quarter worth about $57,000. Jump Financial LLC acquired a new position in Aveanna Healthcare in the first quarter valued at about $59,000. Finally, MQS Management LLC bought a new stake in shares of Aveanna Healthcare in the second quarter worth about $59,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AVAH has been the topic of several recent research reports. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price on the stock. Royal Bank Of Canada increased their price objective on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their target price for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Raymond James Financial reissued an “outperform” rating and issued a $13.00 price target on shares of Aveanna Healthcare in a research note on Friday, December 5th. Finally, Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $10.69.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.